Blood Proteins FGF2 and PRDX3 Fail to Improve Long COVID Prediction Across Cohorts
A rigorous cross-cohort analysis finds that the blood proteins FGF2 and PRDX3, measured during acute COVID-19, do not reliably improve ...
A rigorous cross-cohort analysis finds that the blood proteins FGF2 and PRDX3, measured during acute COVID-19, do not reliably improve ...
A network-based analysis of molecular dynamics simulations shows that SARS-CoV-2 forms more robust connections with the human ACE2 receptor than ...
A University of Tokyo study shows the adjuvant K3-SPG can train innate immunity in mice to provide temporary protection against ...
A mathematical modeling study finds that rapid, less accurate tests can outperform slower PCR-style testing during outbreaks, but only when ...
A three-year Chinese hospital study of 519 children with COVID-19 found that hyponatremia and elevated neutrophil count were the only ...
A serosurvey of 3,656 blood donors in Niamey found SARS-CoV-2 antibodies in over half of unvaccinated participants, revealing extensive undetected ...
A new Journal of General Internal Medicine review gives primary care clinicians a pragmatic framework for diagnosing and managing Long ...
A randomized phase 2a trial found the SARS-CoV-2 monoclonal antibody AER002 safe but ineffective for Long COVID overall, though post-hoc ...
Single-cell TCR sequencing shows that SARS-CoV-2-specific CD8 T cells recognize a tumor-associated antigen through molecular mimicry, supporting viral-mimic cancer vaccines.
Researchers have generalized the Pango lineage nomenclature that tracked SARS-CoV-2 variants into a unified framework for naming viral diversity across ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine